New User? Sign Up | Sign In

Sec Form 4 Filing - Jovan-Embiricos Morana @ Cullinan Management Inc. - 2021-01-12

  1. About Form 4 Filing: Every director, officer or owner of more than ten percent of a class of equity securities registered under Section 12 of the '34 Act must file with the U.S. Securities and Exchange Commission (SEC) a statement of ownership regarding such security. The initial filing is on Form 3 and changes are reported on Form 4. The Annual Statement of beneficial ownership of securities is on Form 5. The forms contain information on the reporting person's relationship to the company and on purchases and sales of such equity securities.
  2. Form 4 is stored in SEC's EDGAR database. EDGAR is Electronic Data Gathering, Analysis and Retrieval System. It is a registered trademark of the SEC.

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Email a friend >>...

SPAC List: List of Special Purpose Acquisition Companies


The following is an SEC EDGAR document rendered as filed.
Here is the list of insider trading transaction codes.

FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person *
Jovan-Embiricos Morana
2. Issuer Name and Ticker or Trading Symbol
Cullinan Management, Inc. [ CGEM]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X __ Director X __ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last)
(First)
(Middle)
C/O CULLINAN MANAGEMENT, INC., ONE MAIN STREET, SUITE 520
3. Date of Earliest Transaction (MM/DD/YY)
01/12/2021
(Street)
CAMBRIDGE, MA02142
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
_____ Form filed by One Reporting Person
__ X __ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 112,507 D
Common Stock 01/12/2021 C 1,136,525 A 1,136,525 I See Footnote ( 2 )
Common Stock 01/12/2021 C 2,912,345 A 2,912,345 I See Footnote ( 3 )
Common Stock 01/12/2021 C 639,295 A 639,295 I See Footnote ( 4 )
Common Stock 01/12/2021 C 455,338 A 455,338 I See Footnote ( 5 )
Common Stock 01/12/2021 C 182,135 A 182,135 I See Footnote ( 6 )
Common Stock 01/12/2021 C 71,599 A 526,937 I See Footnote ( 5 )
Common Stock 01/12/2021 C 143,198 A 325,333 I See Footnote ( 6 )
Common Stock 01/12/2021 C 71,599 A 71,599 I See Footnote ( 7 )
Common Stock 01/12/2021 C 214,798 A 214,798 I See Footnote ( 8 )
Common Stock 01/12/2021 P 95,238 A $ 21 622,175 I See Footnote ( 5 )
Common Stock 01/12/2021 P 104,762 A $ 21 104,762 I See Footnote ( 9 )
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Series Seed Convertible Preferred Stock ( 1 ) 01/12/2021 C 8,000,000 ( 1 ) ( 1 ) Common Stock 1,136,525 $ 0 0 I See Footnote ( 2 )
Series A Convertible Preferred Stock ( 1 ) 01/12/2021 C 20,500,000 ( 1 ) ( 1 ) Common Stock 2,912,345 $ 0 0 I See Footnote ( 3 )
Series A Convertible Preferred Stock ( 1 ) 01/12/2021 C 4,500,000 ( 1 ) ( 1 ) Common Stock 639,295 $ 0 0 I See Footnote ( 4 )
Series B Convertible Preferred Stock ( 1 ) 01/12/2021 C 3,205,128 ( 1 ) ( 1 ) Common Stock 455,338 $ 0 0 I See Footnote ( 5 )
Series B Convertible Preferred Stock ( 1 ) 01/12/2021 C 1,282,051 ( 1 ) ( 1 ) Common Stock 182,135 $ 0 0 I See Footnote ( 6 )
Series C Convertible Preferred Stock ( 1 ) 01/12/2021 C 503,988 ( 1 ) ( 1 ) Common Stock 71,599 $ 0 0 I See Footnote ( 5 )
Series C Convertible Preferred Stock ( 1 ) 01/12/2021 C 1,007,977 ( 1 ) ( 1 ) Common Stock 143,198 $ 0 0 I See Footnote ( 6 )
Series C Convertible Preferred Stock ( 1 ) 01/12/2021 C 503,988 ( 1 ) ( 1 ) Common Stock 71,599 $ 0 0 I See Footnote ( 7 )
Series C Convertible Preferred Stock ( 1 ) 01/12/2021 C 1,511,966 ( 1 ) ( 1 ) Common Stock 214,798 $ 0 0 I See Footnote ( 8 )
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Jovan-Embiricos Morana
C/O CULLINAN MANAGEMENT, INC.
ONE MAIN STREET, SUITE 520
CAMBRIDGE, MA02142
X X
Globeways Holdings Ltd
C/O LJ PARTNERSHIP, 8, RUE SAINT-LEGER,
GENEVA, V8CH-1205
X
F2 Vision SCS
C/O ATALUX
74 GRAND-RUE
LUXEMBOURG, V8L-1660
X
F2 Bioscience I 2017 Ltd
C/O LJ PARTNERSHIP, 8, RUE SAINT-LEGER,
GENEVA, V8CH-1205
X
F2 MG Ltd
C/O LJ PARTNERSHIP, 8, RUE SAINT-LEGER
GENEVA, V8CH-1205
X
F2 - TPO Investments LLC
C/O SINGER, MCKEON INC.
8 WEST 38TH STREET, SUITE 1001
NEW YORK, NY10018
X
F2 Bio TD, LLC
C/O SINGER, MCKEON INC.
8 WEST 38TH STREET, SUITE 1001
NEW YORK, NY10018
X
F2 MC, LLC
C/O SINGER, MCKEON INC.
8 WEST 38TH STREET, SUITE 1001
NEW YORK, NY10018
X
F2 GC, LLC
C/O SINGER, MCKEON INC.
8 WEST 38TH STREET, SUITE 1001
NEW YORK, NY10018
X
Signatures
/s/ Morana Jovan-Embiricos 01/14/2021
** Signature of Reporting Person Date
/s/ Morana Jovan-Embiricos for Globeways Holdings Limited 01/14/2021
** Signature of Reporting Person Date
/s/ Alain Renard and Christian Francois for F2 Vision SCS 01/14/2021
** Signature of Reporting Person Date
/s/ Rachel Higham and Ivan Bedford for F2 Bioscience I 2017 Limited 01/14/2021
** Signature of Reporting Person Date
/s/ Morana Jovan-Embiricos for F2-TPO Investments, LLC 01/14/2021
** Signature of Reporting Person Date
/s/ Rachel Higham and Ivan Bedford for F2 MG Limited 01/14/2021
** Signature of Reporting Person Date
/s/ Morana Jovan-Embiricos for F2 Bio TD, LLC 01/14/2021
** Signature of Reporting Person Date
/s/ Morana Jovan-Embiricos for F2 MC, LLC 01/14/2021
** Signature of Reporting Person Date
/s/ Morana Jovan-Embiricos for F2 GC, LLC 01/14/2021
** Signature of Reporting Person Date
Explanation of Responses:
( 1 )Each share of Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (the "Preferred Stock') converted into Common Stock of the Issuer on a 1-for-7.0390 basis at the closing of the Issuer's initial public offering on January 12, 2021. The Preferred Stock had no expiration date.
( 2 )These securities are owned directly by Globeways Holdings Limited ("Globeways"). The Reporting Person is the founding director of Globeways and has the sole power to vote upon the acquisition, holding and disposal of all shares held by Globeways. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
( 3 )These securities are owned directly by F2 Vision SCS ("F2 Vision"). F2 Vision Management Sarl ("F2 Vision Management") is the appointed manager of F2 Vision. The Reporting Person is the founding director of F2 Vision Management and has the sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Vision. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
( 4 )These securities are owned directly by F2 Bioscience I 2017 Limited ("F2 Bioscience 2017"). Globeways is the appointed manager of F2 Bioscience 2017. The Reporting Person is the founding director of Globeways and has the sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Bioscience 2017. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
( 5 )These securities are owned directly by F2-TPO Investments, LLC ("F2-TPO"). Globeways Holdings II Limited ("Globeways II") is the appointed manager of F2-TPO. The Reporting Person is the founding director of Globeways II and has the sole power to vote upon the acquisition, holding and disposal of all shares held by F2-TPO. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
( 6 )These securities are owned directly by F2 MG Limited ("F2 MG"). Globeways is the appointed manager of F2 MG. The Reporting Person is the founding director of Globeways and has the sole power to vote upon the acquisition, holding and disposal of all shares held by F2 MG. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
( 7 )These securities are owned directly by F2 Bio TD, LLC ("F2 Bio"). Globeways II is the appointed manager of F2 Bio. The Reporting Person is the founding director of Globeways II and has the sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Bio. . The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
( 8 )These securities are owned directly by F2 MC, LLC ("F2 MC"). Globeways II is the appointed manager of F2 MC. The Reporting Person is the founding director of Globeways II and has the sole power to vote upon the acquisition, holding and disposal of all shares held by F2 MC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
( 9 )These securities are owned directly by F2 GC LLC ("F2 GC"). Globeways II is the appointed manager of F2 GC. The Reporting Person is the founding director of Globeways II and has the sole power to vote upon the acquisition, holding and disposal of all shares held by F2 GC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.